26 /100
MEDIUM RISK
Score updated May 30, 2026

AMLX — Amylyx Pharmaceuticals, Inc. Dilution Risk Tracker

Track AMLX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track AMLX — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
25
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for AMLX.
🔔 Track AMLX — Get forecast alerts →

💹 Market Data

Market Cap$1.60B
Shares Outstanding111.19M
Float83.53M
Cash$279.77M
Debt$5.63M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 4.4% shares (2025Q4 vs prior)
180 institutional holders · 118.03M shares
#1 FMR LLC 16.52M shares
#2 BlackRock, Inc. 9.05M shares
#3 PERCEPTIVE ADVISORS LLC 8.28M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest14.51M
Days to Cover12.2
% of Float17.4%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2022
4 INSIDER TRANSACTION Mar 09, 2026
4 INSIDER TRANSACTION Mar 09, 2026
4 INSIDER TRANSACTION Mar 09, 2026
4 INSIDER TRANSACTION Mar 09, 2026
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track AMLX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking AMLX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: ADAG AIEV AIP ALLO ALOY
🔬 More Research for AMLX
📊 AMLX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 AMLX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.